Clara Health

Executive Summary

Clara Health, a digital health company based in San Francisco, operates a patient-centric platform that connects individuals with clinical trials through 24/7 live navigator support. Founded in 2015, the company aims to make clinical trials accessible to all by helping patients find and access new study treatments from anywhere. In a strategic move to expand its reach and capabilities, Clara Health was acquired by M&B Sciences Inc., a technology-driven clinical research organization (CRO). This acquisition aligns with Clara Health's mission to streamline patient recruitment and improve trial enrollment efficiency, leveraging M&B's existing infrastructure and expertise in clinical research. The combined entity is poised to enhance its digital platform, potentially integrating advanced data analytics and AI to better match patients with suitable trials, thereby reducing the time and cost associated with patient recruitment. Looking ahead, Clara Health's integration with M&B Sciences presents both opportunities and challenges. The company must navigate post-acquisition synergies, including technology integration and cultural alignment, to fully realize its potential. While the clinical trial matching market is growing, competition from other digital health platforms and CROs remains intense. Clara Health's success will depend on its ability to maintain patient trust, expand its trial database, and demonstrate measurable improvements in enrollment outcomes. With a relatively low profile and limited public information, the company's near-term impact is uncertain, but its patient-focused approach and backing by a CRO provide a foundation for gradual growth.

Upcoming Catalysts (preview)

• Q3 2026Integration of Clara Health platform with M&B Sciences' technology stack60% success
• Q4 2026Announcement of new partnerships with pharmaceutical companies for trial recruitment50% success
• Q1 2027Launch of AI-powered patient-trial matching feature45% success